Clinical Trials Logo

Clinical Trial Summary

Myasthenia gravis is an autoimmune disorder of neuromuscular transmission, characterized by fluctuating muscle weakness and fatigability. In isolated ocular myasthenia, when only the extraocular muscles are involved, most common ancillary tests, such as acetylcholine receptor autoantibodies and repetitive nerve stimulation, are often negative. A simple, quick and non-invasive test for ocular myasthenia based on ocular vestibular evoked myogenic potentials (oVEMP) was recently developed. The main goal of the study is to validate repetitive oVEMP stimulation in a blinded diagnostic accuracy study in order to facilitate early and accurate diagnosis of ocular myasthenia.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03049956
Study type Interventional
Source University of Zurich
Contact
Status Completed
Phase N/A
Start date November 1, 2016

See also
  Status Clinical Trial Phase
Completed NCT05380128 - Association Study Between VDR Gene Polymorphisms and Risk and Features of MG in Han Chinese Population
Recruiting NCT05214612 - Predictors and Prognostic Factors of Myasthenia Gravis Outcome